LYEL - Lyell Immunopharma Chief Financial Officer Acquires 4818000 Shares After Exercising Company Stock Options | Benzinga
Charles Newton, Chief Financial Officer at Lyell Immunopharma (NASDAQ:LYEL), reported a large exercise of company stock options on November 21, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Newton, Chief Financial Officer at Lyell Immunopharma, a company in the Health Care sector, just exercised stock options worth 4,818,000 shares of LYEL stock with an exercise price of $6.21.
Lyell Immunopharma shares are trading down 1.03% at $1.92 at the time of this writing on Tuesday morning. Since the current price is $1.92, this makes Newton's 4,818,000 shares worth $9,250,560.